177 related articles for article (PubMed ID: 11815384)
21. Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior.
Alekseev AE; Kennedy ME; Navarro B; Terzic A
J Membr Biol; 1997 Sep; 159(2):161-8. PubMed ID: 9307442
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of terfenadine block of ATP-sensitive K(+) channels.
Zünkler BJ; Kühne S; Rustenbeck I; Ott T
Br J Pharmacol; 2000 Aug; 130(7):1571-4. PubMed ID: 10928959
[TBL] [Abstract][Full Text] [Related]
23. Effects of intracellular MgADP and acidification on the inhibition of cardiac sarcolemmal ATP-sensitive potassium channels by propofol.
Yamada H; Kawano T; Tanaka K; Yasui S; Mawatari K; Takahashi A; Nakaya Y; Oshita S
J Anesth; 2007; 21(4):472-9. PubMed ID: 18008114
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.
Weyermann A; Vollert H; Busch AE; Bleich M; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):374-81. PubMed ID: 15024553
[TBL] [Abstract][Full Text] [Related]
25. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
Shindo T; Katayama Y; Horio Y; Kurachi Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
Gopalakrishnan M; Molinari EJ; Shieh CC; Monteggia LM; Roch JM; Whiteaker KL; Scott VE; Sullivan JP; Brioni JD
Br J Pharmacol; 2000 Apr; 129(7):1323-32. PubMed ID: 10742287
[TBL] [Abstract][Full Text] [Related]
27. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
28. 17Beta-estradiol regulates expression of K(ATP) channels in heart-derived H9c2 cells.
Ranki HJ; Budas GR; Crawford RM; Davies AM; Jovanović A
J Am Coll Cardiol; 2002 Jul; 40(2):367-74. PubMed ID: 12106946
[TBL] [Abstract][Full Text] [Related]
29. Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A.
Lorenz E; Terzic A
J Mol Cell Cardiol; 1999 Feb; 31(2):425-34. PubMed ID: 10093054
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of the inhibitory effects of clonidine on vascular adenosine triphosphate-sensitive potassium channels.
Kawahito S; Kawano T; Kitahata H; Oto J; Takahashi A; Takaishi K; Harada N; Nakagawa T; Kinoshita H; Azma T; Nakaya Y; Oshita S
Anesth Analg; 2011 Dec; 113(6):1374-80. PubMed ID: 22003223
[TBL] [Abstract][Full Text] [Related]
31. The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener.
Dabrowski M; Ashcroft FM; Ashfield R; Lebrun P; Pirotte B; Egebjerg J; Bondo Hansen J; Wahl P
Diabetes; 2002 Jun; 51(6):1896-906. PubMed ID: 12031979
[TBL] [Abstract][Full Text] [Related]
32. Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP).
Flagg TP; Remedi MS; Masia R; Gomes J; McLerie M; Lopatin AN; Nichols CG
J Mol Cell Cardiol; 2005 Oct; 39(4):647-56. PubMed ID: 16099470
[TBL] [Abstract][Full Text] [Related]
33. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
[TBL] [Abstract][Full Text] [Related]
34. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
Fang K; Csanády L; Chan KW
J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
[TBL] [Abstract][Full Text] [Related]
35. Cystic fibrosis transmembrane conductance regulator mediates sulphonylurea block of the inwardly rectifying K+ channel Kir6.1.
Ishida-Takahashi A; Otani H; Takahashi C; Washizuka T; Tsuji K; Noda M; Horie M; Sasayama S
J Physiol; 1998 Apr; 508 ( Pt 1)(Pt 1):23-30. PubMed ID: 9490811
[TBL] [Abstract][Full Text] [Related]
36. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
[TBL] [Abstract][Full Text] [Related]
37. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.
Meyer M; Chudziak F; Schwanstecher C; Schwanstecher M; Panten U
Br J Pharmacol; 1999 Sep; 128(1):27-34. PubMed ID: 10498831
[TBL] [Abstract][Full Text] [Related]
38. Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes.
Gribble FM; Ashfield R; Ammälä C; Ashcroft FM
J Physiol; 1997 Jan; 498 ( Pt 1)(Pt 1):87-98. PubMed ID: 9023770
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for the interference between nicorandil and sulfonylurea action.
Reimann F; Ashcroft FM; Gribble FM
Diabetes; 2001 Oct; 50(10):2253-9. PubMed ID: 11574406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
